Journal Article

Oxymorphone-Involved Fatalities: A Report of Two Cases

Iain M. McIntyre, James L. Sherrard and Craig L. Nelson

in Journal of Analytical Toxicology

Volume 33, issue 9, pages 615-619
Published in print November 2009 | ISSN: 0146-4760
Published online November 2009 | e-ISSN: 1945-2403 | DOI:
Oxymorphone-Involved Fatalities: A Report of Two Cases

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)


Show Summary Details


There has been an increased awareness of illicit opiate abusers using the narcotic oxymorphone (Opana®) by inhalation. Many laboratory screening techniques currently in use cannot detect oxymorphone in blood or urine. Consequently, biological specimens containing low to moderate concentrations of oxymorphone will likely go undetected. The circumstances, pathology findings, and toxicology results of two fatalities involving oxymorphone are presented. An opiate confirmation gas chromatography-mass spectrometry (GC-MS) procedure, described in detail was able to detected, confirm, and quantify oxymorphone in both subjects. The blood concentrations were 0.05 mg/L (50 µg/L) and 0.12 mg/L (120 µg/L).

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.